Fig. 5From: Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expressionFACS analysis of the surface FLT3 expression level. a Cells treated with rhFL, DM1 or FL-DM1 for 1Â h. DM1: 100Â nM. Recombinant hFL: 5Â nM. FL-DM1: 5Â nM. b Cells were treated for different time (1Â h, 2Â h, and 4Â h) with FL-DM1 (5Â nM)Back to article page